685 related articles for article (PubMed ID: 2168934)
1. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
[TBL] [Abstract][Full Text] [Related]
3. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
[TBL] [Abstract][Full Text] [Related]
4. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
[TBL] [Abstract][Full Text] [Related]
6. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
[TBL] [Abstract][Full Text] [Related]
7. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
Van Vliet BJ; De Vries TJ; Wardeh G; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Oct; 208(2):105-11. PubMed ID: 1666051
[TBL] [Abstract][Full Text] [Related]
8. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):278-84. PubMed ID: 3035383
[TBL] [Abstract][Full Text] [Related]
10. Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices.
De Vries TJ; Schoffelmeer AN; Delay-Goyet P; Roques BP; Mulder AH
Eur J Pharmacol; 1989 Nov; 170(3):137-43. PubMed ID: 2575993
[TBL] [Abstract][Full Text] [Related]
11. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum.
Schoffelmeer AN; Rice KC; Heijna MH; Hogenboom F; Mulder AH
Eur J Pharmacol; 1988 Apr; 149(1-2):179-82. PubMed ID: 2840299
[TBL] [Abstract][Full Text] [Related]
12. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
[TBL] [Abstract][Full Text] [Related]
13. Effect of opioid agonists selective for three subclasses of opioid receptors and one sigma receptor agonist on dopamine stimulated adenylate cyclase in rat caudate nucleus.
Grynne BH; Holmen AT; Enger M; Maurset AR
Pharmacol Toxicol; 1991 Nov; 69(5):338-40. PubMed ID: 1666431
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
Arenas E; Alberch J; Marsal J
Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
[TBL] [Abstract][Full Text] [Related]
17. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
18. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
Passarelli F; Costa T
J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429
[TBL] [Abstract][Full Text] [Related]
19. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
Sbacchi M; La Regina A; Petrillo P; Tavani A
NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
[TBL] [Abstract][Full Text] [Related]
20. Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain--coupling with adenylate cyclase, localisation on the same neurones and association with dopamine (D1) receptor adenylate cyclase.
Eriksson PS; Hansson E; Rönnbäck L
Neuropharmacology; 1991 Nov; 30(11):1233-9. PubMed ID: 1663598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
